The Danish renewable-energy company said late Monday that its Sunrise Wind project off the coast of New York is navigating supply chain and construction challenges, which have resulted in delays and ...

Other AbbVie drugs, including its once-best-selling multiuse medication Humira, have been targeted by new provisions in the ...

Shares of Walgreens Boots Alliance (NASDAQ: WBA) fell sharply last year as a combination of declining vaccine demand, ...

Walgreens Boots Alliance surged by >25% today, following strong Q1 2025 earnings and revenue outperformance. Click here to ...

Walgreens Boots Alliance (NASDAQ:WBA) recently reported its fourth-quarter earnings for 2024, revealing a significant decline in its adjusted earnings per share (EPS) by 41% year-over-year to $0.39.

Morningstar Research Services’ chief market strategist Dave Sekera discusses where stocks look especially expensive in the US today, as well as pockets of value. Maintaining independence and ...

Walgreens Boots Alliance, Inc. (NASDAQ ... The company reported a $526 million operating loss in the fourth quarter, largely ...

In this article, we are going to take a look at where Walgreens Boots Alliance, Inc. (NASDAQ:WBA) stands against the other stocks Jim Cramer recently discussed. Jim Cramer, host of Mad Money ...

Walgreens Boots Alliance, Inc. (Nasdaq: WBA) today announced financial results for the first quarter of fiscal 2025, which ended November 30, 2024. Chief Executive Officer Tim Wentworth said: "Our ...

Walgreens Boots Alliance is making progress on a plan to close 1,200 stores over the next three years as it aims to right-size the company and consider strategic options, including a potential ...

January 10, 2025--(BUSINESS WIRE)--Walgreens Boots Alliance ... the amount of our goodwill impairment charge (which is based in part on estimates of future performance), the influence of certain ...